Immunosuppression medication and cardiac function improvement treatments might prevent Takayasu arteritis patients with aortitis from receiving cardiac surgery
Main Authors: | Xiao-Min Dai, Yu-Jiao Wang, Zhen-Chun Zhang, Cheng-De Yang, Rui Wu, Zhen-Yuan Zhou, Xiao-Xiang Chen, Xiao-Ning Sun, Chun-Sheng Wang, Li-Li Ma, Lin-Di Jiang, Jing Ni, Li-Shao Guo, and the East China Takayasu Arteritis (ECTA) Collaboration Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2021-03-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000001160 |
Similar Items
-
Takayasu's Arteritis: Cardiac and Renal Involvement
by: Vitorino Modesto dos Santos
Published: (2019-01-01) -
Concurrence of Sarcoidosis and Takayasu Aortitis
by: Yuan Liu, et al.
Published: (2015-01-01) -
Unusual presentation of Takayasu's arteritis with cardiac involvement and renal artery stenosis
by: Zahra Khajali, et al.
Published: (2018-01-01) -
Takayasu Arteritis
by: Ricardo A. G. Russo, et al.
Published: (2018-09-01) -
Perioperative Management of Takayasu Arteritis for Cardiac Surgery in a Patient Treated With Tocilizumab
by: Yoh Arita, MD, PhD, et al.
Published: (2020-12-01)